Capricor Therapeutics Inc. (NASDAQ: CAPR)
$4.85
+0.1900 ( +4.08% ) 138.5K
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
Market Data
Open
$4.85
Previous close
$4.66
Volume
138.5K
Market cap
$155.10M
Day range
$4.68 - $4.89
52 week range
$2.68 - $8.22
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | May 15, 2024 |
| 8-k | 8K-related | 13 | May 15, 2024 |
| 10-q | Quarterly Reports | 57 | May 14, 2024 |
| 8-k | 8K-related | 15 | May 13, 2024 |
| 8-k | 8K-related | 42 | Apr 29, 2024 |
| 4 | Insider transactions | 1 | Apr 25, 2024 |
| 4 | Insider transactions | 1 | Apr 24, 2024 |
| def | Proxies and info statements | 19 | Apr 01, 2024 |
| ars | Annual reports | 1 | Apr 01, 2024 |
| pre | Proxies and info statements | 18 | Mar 20, 2024 |